The Economics of Drug Development: Why Bringing a New Medicine to Market Costs Billions
International Journal of All Research Education and Scientific Methods · 2026 · 14 (11) · 344-355
DOI: 10.56025/ijaresm.14112644 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of All Research Education and Scientific Methods, 2026. Verfasst von Shiv Patel.
Abstract (Originalsprache)
Developing a new drug is a multistage, complex, uncertain and expensive process which impacts not only pharmaceutical companies and their investors but also has far-reaching implications for patients, healthcare systems and public health. A drug needs to go through various stages spread over many years before being considered for patient use. The various stages include compound discovery, preclinical testing, clinical trials and regulatory review. The process is also extremely expensive, requiring billions of dollars of investment in research and development. This paper examines why developing a new medicine can cost billions of dollars and how different kinds of drugs require different levels of investment and have their own unique challenges. The study compares four case studies: Moderna’s mRNA vaccines, Biogen’s Alzheimer’s drug development, Vertex Pharmaceuticals’ rare-disease treatments, and Bristol Myers Squibb’s oncology immunotherapy.
Zitieren
APA
Patel, S. (2026). The Economics of Drug Development: Why Bringing a New Medicine to Market Costs Billions. International Journal of All Research Education and Scientific Methods, 14(11), 344-355. https://doi.org/10.56025/ijaresm.14112644
Vancouver
Patel S. The Economics of Drug Development: Why Bringing a New Medicine to Market Costs Billions. International Journal of All Research Education and Scientific Methods. 2026;14(11):344-355. doi:10.56025/ijaresm.14112644
BibTeX
@article{Patel2026,
author = {Patel, Shiv},
title = {The Economics of Drug Development: Why Bringing a New Medicine to Market Costs Billions},
journal = {International Journal of All Research Education and Scientific Methods},
year = {2026},
volume = {14},
number = {11},
pages = {344--355},
doi = {10.56025/ijaresm.14112644}
}
EUVIMED